about
Pharmacotherapy and airway remodelling in asthma?Asthma versus chronic obstructive pulmonary disease--exploring why 'reversibility versus irreversibility' is no longer an appropriate approach.Longitudinal decline in lung function in patients with occupational asthma due to western red cedar.Why does airway inflammation persist? Is it failure to treat early?Differential diagnosis of chronic airflow obstruction.Childhood asthma in adult life: a further study at 28 years of ageFeatures of asthma in the elderly.Fixed airways obstruction among patients with severe asthma: findings from the Singapore General Hospital-Severe Asthma Phenotype Study.The role of ozone exposure in the epidemiology of asthma.Childhood-onset asthma in smokers. association between CT measures of airway size, lung function, and chronic airflow obstruction.Role of Th2 responses in the development of allergen-induced airway remodelling in a murine model of allergic asthma.Angiotensin-(1-7) attenuates airway remodelling and hyperresponsiveness in a model of chronic allergic lung inflammationIncrease in exhaled nitric oxide levels in patients with difficult asthma and correlation with symptoms and disease severity despite treatment with oral and inhaled corticosteroids. Asthma and Allergy Group.High resolution computed tomographic assessment of airway wall thickness in chronic asthma: reproducibility and relationship with lung function and severityRisk factors associated with the presence of irreversible airflow limitation and reduced transfer coefficient in patients with asthma after 26 years of follow upAsthma and incident cardiovascular disease: the Atherosclerosis Risk in Communities Study.Do chesty children become chesty adults?Biology and therapeutic potential of the interleukin-4/interleukin-13 signaling pathway in asthma.Is forced expiratory volume in one second the best measure of severity in childhood asthma?Prevalence and diagnosis of chronic respiratory symptoms in adultsRespiratory symptoms as predictors of 27 year mortality in a representative sample of British adults.Future research directions in asthma: an NHLBI Working Group report.Evaluation of emphysema in patients with asthma using high-resolution CT.Definitions of emphysema, chronic bronchitis, asthma, and airflow obstruction: 25 years on from the Ciba symposiumA self management plan in the treatment of adult asthma.Genetics and the Dutch Hypothesis.Relationship between the inflammatory infiltrate in bronchial biopsy specimens and clinical severity of asthma in patients treated with inhaled steroidsComparison of terbutaline and placebo from a pressurised metered dose inhaler and a dry powder inhaler in a subgroup of patients with asthmaDecline of lung function and development of chronic airflow limitation: a longitudinal study of non-smokers and smokers in Busselton, Western Australia.The relationship between age and duration of asthma and the presence of persistent obstruction in asthma.The influence of social factors on the control of asthma.Time sequence of airway remodeling in a mouse model of chronic asthma: the relation with airway hyperresponsivenessA Quantitative Study of Airway Changes on Micro-CT in a Mouse Asthma Model: Comparison With Histopathological Findings.Asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS): current literature review.Growing old with asthma: what are the changes and challenges?High resolution computed tomographic evaluation of bronchial wall thickness in healthy and clinically asthmatic cats.The independent and combined effects of lifetime smoke exposures and asthma as they relate to COPD.The asthma COPD overlap syndrome (ACOS).Once-daily fluticasone furoate/vilanterol versus twice daily combination therapies in asthma-mixed treatment comparisons of clinical efficacy.Oncostatin M (OSM) is increased in asthma with incompletely reversible airflow obstruction.
P2860
Q24678822-804FD747-C8F1-46AF-8BE3-3A2333554ECBQ33640272-D528ACC4-1F06-438B-9581-CF4C5737FAB4Q33820203-6AF9CCFF-6BD1-4ED3-A742-E055F6963DEBQ33860271-D8F47F1E-D798-4F6B-94B0-E4EB8DA93D80Q33930072-61BCD7DE-146D-4E02-9D82-61C54A8AE363Q34069857-1D3CAAC4-AFAD-47B9-A78E-C1CF5703852CQ34342751-B1694388-FBF2-4952-9F24-805D05AAEA41Q34695211-2D50F927-6927-4B93-A4F2-75C948725B63Q34845691-8C035CA6-FB42-40B7-9B6E-9983F6FB5F91Q34984718-4BAA1D2E-E6CA-4856-8B5F-D0A3B4E64281Q35045023-6FC8A6E8-5C75-4DB2-8143-F8A7CF9A243AQ35484382-80120D1A-9FD3-40C9-9BCF-EBF50EB49F68Q35532164-ABD7400A-53DF-4D65-B5E4-B82CA17EEA24Q35535050-8211FDAD-158E-4A4E-826D-87D8963AECD9Q35535853-5E0C1127-0182-41DD-AE09-C26658C8409FQ35537919-8E6391B1-D11E-4928-BFD0-4382B541020DQ35625022-1A5D2C7A-C635-4882-AD94-23EAB7B23E7AQ35627845-806E2E30-944A-41EF-B376-D4825A122C3DQ35644751-653CB469-D179-4DEF-B3BD-12C471968563Q35713060-3B8CE32D-C938-460E-A5D0-8EEB246BE400Q35714918-81D44E11-FF57-4BCB-BC6C-DF01AC903682Q35816138-C6657E7B-0B8D-4204-9C2C-488A9EA7E55AQ35937256-106CBE2B-0030-43E0-9B0D-0BF267E631EAQ36134544-80F4421B-6A66-4254-8175-F9CDE060C15DQ36198195-8F3DF3D2-071E-44E4-ADE3-9C744DEF90A1Q36309975-CDB7DD62-DFF0-4892-9EAB-D7DBC729CE17Q36528911-E0F2C237-DD7C-427F-A7E0-F9A58240F466Q36579047-98B09C1F-E7B6-49F8-9F21-A106F8F77A4AQ36587759-B254E3BF-D482-4B0F-9ED3-695DD605F8B0Q36722384-39510564-2BF6-41D2-BDD8-860EF81504F1Q36723126-17CE63C1-6D06-45E7-B5CE-4BDF435CD30DQ37220309-EE60EAF8-DE10-4DDF-BE76-40DFBE7467F9Q37436005-F061BF13-E611-49D4-9118-ACCAEEC53974Q37663904-86A4CBCC-C39F-425C-95D7-026778E57217Q37734453-3BCBF288-3EF6-48F5-B3B4-4ED9058B2DEEQ37740098-C10A61EB-9CCB-4B93-B8B7-ADC1F50432DFQ38212257-791CBEDC-6B60-42AA-A33A-89C4509C6BF5Q38364870-59BB7106-206D-4899-A87B-683BCD85A291Q39038011-A858FDB7-2E0A-4AC4-8D76-9FBCC2E6A2D9Q39774052-36E7462D-DF50-4112-9D57-FD462E5E12D4
P2860
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
1984年论文
@zh
1984年论文
@zh-cn
name
Asthma and irreversible airflow obstruction
@ast
Asthma and irreversible airflow obstruction
@en
type
label
Asthma and irreversible airflow obstruction
@ast
Asthma and irreversible airflow obstruction
@en
prefLabel
Asthma and irreversible airflow obstruction
@ast
Asthma and irreversible airflow obstruction
@en
P2093
P2860
P356
P1433
P1476
Asthma and irreversible airflow obstruction
@en
P2093
Finucane KE
Greville HW
P2860
P304
P356
10.1136/THX.39.2.131
P407
P577
1984-02-01T00:00:00Z